Evidence map›Paper›PMID 25242222›Full record

ArticleNeuron2014

GINIP, a Gαi-interacting protein, functions as a key modulator of peripheral GABAB receptor-mediated analgesia.

Stéphane Gaillard, Laure Lo Re, Annabelle Mantilleri, Régine Hepp, Louise Urien, Pascale Malapert, Serge Alonso, Michael Deage, Charline Kambrun, Marc Landry and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuron, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. GABAMedComm · 2025
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. A novel NaiScience · 2024
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 2 countries.

Stéphane GaillardAix-Marseille-Université, CNRS, Institut de Biologie du Développement de Marseille, UMR 7288, case 907, 13288 Marseille Cedex 09, France.
Laure Lo ReAix-Marseille-Université, CNRS, Institut de Biologie du Développement de Marseille, UMR 7288, case 907, 13288 Marseille Cedex 09, France.
Annabelle MantilleriAix-Marseille-Université, CNRS, Institut de Biologie du Développement de Marseille, UMR 7288, case 907, 13288 Marseille Cedex 09, France.
Régine HeppSorbonne Universités, UPMC Univ Paris 06, UM CR 18, Neuroscience Paris Seine, 75005 Paris, France; Centre National de la Recherche Scientifique (CNRS), UMR 8246 Paris, France; Institut national de la Santé et de la Recherche Médicale (INSERM), UMR-S 1130 Paris, France.
Louise UrienAix-Marseille-Université, CNRS, Institut de Biologie du Développement de Marseille, UMR 7288, case 907, 13288 Marseille Cedex 09, France.
Pascale MalapertAix-Marseille-Université, CNRS, Institut de Biologie du Développement de Marseille, UMR 7288, case 907, 13288 Marseille Cedex 09, France.
Serge AlonsoAix-Marseille-Université, CNRS, Institut de Biologie du Développement de Marseille, UMR 7288, case 907, 13288 Marseille Cedex 09, France.
Michael DeageLaboratories of Excellence, Ion Channel Science and Therapeutics, Institut de Génomique Fonctionnelle, UMR 5203, CNRS, U661, INSERM, Universités Montpellier I&II, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France.
Charline KambrunUniversity Bordeaux, Interdisciplinary Institute for Neuroscience, UMR 5297, 33000 Bordeaux, France; CNRS, Interdisciplinary Institute for Neuroscience, UMR 5297, 33000 Bordeaux, France.
Marc LandryUniversity Bordeaux, Interdisciplinary Institute for Neuroscience, UMR 5297, 33000 Bordeaux, France; CNRS, Interdisciplinary Institute for Neuroscience, UMR 5297, 33000 Bordeaux, France.
Sarah A LowDepartment of Anesthesiology, Perioperative and Pain Medicine, Department of Molecular and Cellular Physiology, Stanford Neurosciences Institute, Stanford University, Palo Alto, CA 94304, USA.
Abdelkrim AllouiLaboratoire de Pharmacologie Médicale, Faculté de Médecine et de Pharmacie, UMR 766 INSERM, 28 place Henri-Dunant, BP 38, 63001 Clermont-Ferrand Cedex 1, France.
Bertrand LambolezSorbonne Universités, UPMC Univ Paris 06, UM CR 18, Neuroscience Paris Seine, 75005 Paris, France; Centre National de la Recherche Scientifique (CNRS), UMR 8246 Paris, France; Institut national de la Santé et de la Recherche Médicale (INSERM), UMR-S 1130 Paris, France.
Grégory ScherrerDepartment of Anesthesiology, Perioperative and Pain Medicine, Department of Molecular and Cellular Physiology, Stanford Neurosciences Institute, Stanford University, Palo Alto, CA 94304, USA.
Yves Le FeuvreUniversity Bordeaux, Interdisciplinary Institute for Neuroscience, UMR 5297, 33000 Bordeaux, France; CNRS, Interdisciplinary Institute for Neuroscience, UMR 5297, 33000 Bordeaux, France.
Emmanuel BourinetLaboratories of Excellence, Ion Channel Science and Therapeutics, Institut de Génomique Fonctionnelle, UMR 5203, CNRS, U661, INSERM, Universités Montpellier I&II, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France.
Aziz MoqrichAix-Marseille-Université, CNRS, Institut de Biologie du Développement de Marseille, UMR 7288, case 907, 13288 Marseille Cedex 09, France. Electronic address: aziz.moqrich@univ-amu.fr.
Aix-Marseille Université · FRInstitut Interdisciplinaire de Neuroscience · FRInserm · FRInstitut de Biologie du Développement Marseille · FRSorbonne Université · FRStanford University · USCentre National de la Recherche Scientifique · FRUniversité Clermont Auvergne · FR

Funding

Analgesic Mechanism of Action of Endogenous Opioid Peptides Enkephalins with a FoR00DA031777 · NIDA · STANFORD UNIVERSITY · PI SCHERRER, GREGORY · 2012 to 2014
$737k
Analgesic Mechanism of Action of Endogenous Opioid Peptides Enkephalins with a FoK99DA031777 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SCHERRER, GREGORY · 2011 to 2011
$161k
NIDA NIH HHS DA031777NIDA NIH HHS K99 DA031777NIDA NIH HHS R00 DA031777
6 · The paper itself

Abstract

One feature of neuropathic pain is a reduced GABAergic inhibitory function. Nociceptors have been suggested to play a key role in this process. However, the mechanisms behind nociceptor-mediated modulation of GABA signaling remain to be elucidated. Here we describe the identification of GINIP, a Gαi-interacting protein expressed in two distinct subsets of nonpeptidergic nociceptors. GINIP null mice develop a selective and prolonged mechanical hypersensitivity in models of inflammation and neuropathy. GINIP null mice show impaired responsiveness to GABAB, but not to delta or mu opioid receptor agonist-mediated analgesia specifically in the spared nerve injury (SNI) model. Consistently, GINIP-deficient dorsal root ganglia neurons had lower baclofen-evoked inhibition of high-voltage-activated calcium channels and a defective presynaptic inhibition of lamina IIi interneurons. These results further support the role of unmyelinated C fibers in injury-induced modulation of spinal GABAergic inhibition and identify GINIP as a key modulator of peripherally evoked GABAB-receptors signaling.

Indexed as

Amino Acid SequenceAnalgesiaAnimalsEnkephalin, Ala(2)-MePhe(4)-Gly(5)-Excitatory Postsynaptic PotentialsGanglia, SpinalGTP-Binding Protein alpha Subunits, Gi-GoHEK293 CellsHumansMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicMolecular Sequence DataPain MeasurementRatsEnkephalin, Ala(2)-MePhe(4)-Gly(5)-GTP-Binding Protein alpha Subunits, Gi-GoReceptors, GABA-B

Identifiers

PMID25242222
PMCPMC7348640
OpenAlexW2071010887

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.